^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KRAS G12S

    i
    Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
    Entrez ID:
    3845
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Related tests:
    Apply
    A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors (AMPLIFY-7P) (NCT05726864)
    Phase 1/2
    Elicio Therapeutics
    Recruiting
    Last update posted :
    05/03/2024
    Initiation :
    04/14/2023
    Primary completion :
    11/01/2026
    Completion :
    11/01/2026
    KRAS • NRAS
    |
    KRAS mutation • KRAS G12C • NRAS mutation • KRAS G12D • KRAS G12V • KRAS G12A • KRAS G12 • KRAS G12S • NRAS G12D • NRAS G12 • NRAS G13 • NRAS G12S • NRAS G12V
    |
    ELI-002 7P
    Milciclib in Combination With Gemcitabine in Advanced NSCLC (NCT05651269)
    Phase 2
    Tiziana Life Sciences LTD
    Not yet recruiting
    Last update posted :
    12/15/2022
    Initiation :
    03/15/2023
    Primary completion :
    12/01/2024
    Completion :
    06/01/2025
    KRAS
    |
    KRAS mutation • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G13D • KRAS G12A • KRAS G12 • KRAS G12S • KRAS G13
    |
    gemcitabine • milciclib (TZLS-201)